Cantor Fitzgerald Predicts ASND FY2025 Earnings
Ascendis Pharma A/S (NASDAQ:ASND – Free Report) – Analysts at Cantor Fitzgerald issued their FY2025 earnings estimates for Ascendis Pharma A/S in a report released on Tuesday, February 25th. Cantor Fitzgerald analyst L. Watsek anticipates that the biotechnology company will post earnings of ($2.72) per share for the year. Cantor Fitzgerald currently has a “Overweight” […]
Ascendis Pharma A/S (NASDAQ:ASND – Free Report) – Analysts at Cantor Fitzgerald issued their FY2025 earnings estimates for Ascendis Pharma A/S in a report released on Tuesday, February 25th. Cantor Fitzgerald analyst L. Watsek anticipates that the biotechnology company will post earnings of ($2.72) per share for the year. Cantor Fitzgerald currently has a “Overweight” […]
